The use of serum zinc to prostate-specific antigen ratio as a biomarker in the prediction of prostate biopsy outcomes

To generate a combination of serum zinc (Zn) and prostate-specific antigen (PSA) in an attempt to provide better prediction of prostate biopsy outcomes with Zn/PSA ratios. Diagnostic performances of PSA and Zn/PSA were investigated using receiver operating characteristic and the area under the curve...

Ausführliche Beschreibung